DEERFIELD, Ill.–(BUSINESS WIRE)–Walgreens Boots Alliance, Inc. (Nasdaq: WBA) today announced it has completed its previously announced majority share acquisition of CareCentrix, Inc.—the leading independent home-centered platform that coordinates care to the home for health plans, patients and providers. The majority investment in CareCentrix accelerates Walgreens Health’s capabilities in delivering quality healthcare across a spectrum of settings including primary care, specialty pharmacy ca
STERIS Corporation, a wholly owned operating subsidiary of STERIS plc, agreed to buy Xodus Medical, Inc. for $2.1 billion in cash on October 12, 2026, according to a corporate press release...
Viatris Inc. agreed to purchase Pacira BioSciences Inc. for $36.50 per share in cash on October 8, 2026, establishing an equity valuation of approximately $1.65 billion. The transaction establishes...
Shionogi & Co., Ltd. agreed to acquire IntraBio Inc. for $2.0 billion in an all-cash transaction announced on October 5, 2026. The Japanese pharmaceutical company will purchase 100 percent of the...
GE HealthCare announced on October 5, 2026, that it agreed to purchase SOFIE Biosciences from private equity firm Trilantic North America for $945 million in cash. SOFIE Biosciences operates as a...
